nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—stomach cancer	0.21	1	CbGaD
Bumetanide—SLC22A7—Fluorouracil—stomach cancer	0.101	0.26	CbGbCtD
Bumetanide—SLC22A7—Docetaxel—stomach cancer	0.0774	0.198	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—stomach cancer	0.0586	0.15	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—stomach cancer	0.0559	0.143	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—stomach cancer	0.0392	0.1	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—stomach cancer	0.0341	0.0874	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—stomach cancer	0.0238	0.0609	CbGbCtD
Bumetanide—SLC10A1—bile—stomach cancer	0.0155	0.14	CbGeAlD
Bumetanide—CFTR—gall bladder—stomach cancer	0.00518	0.0468	CbGeAlD
Bumetanide—Ear discomfort—Capecitabine—stomach cancer	0.00479	0.0413	CcSEcCtD
Bumetanide—CA9—gall bladder—stomach cancer	0.00448	0.0405	CbGeAlD
Bumetanide—Hypochloraemia—Epirubicin—stomach cancer	0.00354	0.0305	CcSEcCtD
Bumetanide—Hypochloraemia—Doxorubicin—stomach cancer	0.00328	0.0282	CcSEcCtD
Bumetanide—CFTR—hematopoietic system—stomach cancer	0.00293	0.0265	CbGeAlD
Bumetanide—Electrolyte imbalance—Irinotecan—stomach cancer	0.00281	0.0242	CcSEcCtD
Bumetanide—CFTR—epithelium—stomach cancer	0.00268	0.0242	CbGeAlD
Bumetanide—SLC12A5—endocrine gland—stomach cancer	0.00258	0.0233	CbGeAlD
Bumetanide—SLC12A2—hematopoietic system—stomach cancer	0.00257	0.0233	CbGeAlD
Bumetanide—CA5A—endocrine gland—stomach cancer	0.00249	0.0225	CbGeAlD
Bumetanide—CFTR—pancreas—stomach cancer	0.00238	0.0216	CbGeAlD
Bumetanide—SLC12A2—epithelium—stomach cancer	0.00235	0.0213	CbGeAlD
Bumetanide—Furosemide—CA1—stomach cancer	0.00231	0.295	CrCbGaD
Bumetanide—Cramp muscle—Floxuridine—stomach cancer	0.00225	0.0194	CcSEcCtD
Bumetanide—CA5A—liver—stomach cancer	0.00225	0.0203	CbGeAlD
Bumetanide—SLC12A1—hematopoietic system—stomach cancer	0.00216	0.0195	CbGeAlD
Bumetanide—SLC12A4—endocrine gland—stomach cancer	0.00214	0.0194	CbGeAlD
Bumetanide—SLC12A2—pancreas—stomach cancer	0.00209	0.0189	CbGeAlD
Bumetanide—CFTR—digestive system—stomach cancer	0.00204	0.0184	CbGeAlD
Bumetanide—CA7—digestive system—stomach cancer	0.00201	0.0181	CbGeAlD
Bumetanide—SLC12A1—epithelium—stomach cancer	0.00197	0.0178	CbGeAlD
Bumetanide—SLC12A4—liver—stomach cancer	0.00193	0.0175	CbGeAlD
Bumetanide—Serum creatinine increased—Irinotecan—stomach cancer	0.00191	0.0164	CcSEcCtD
Bumetanide—SLC12A2—digestive system—stomach cancer	0.00179	0.0162	CbGeAlD
Bumetanide—CA9—digestive system—stomach cancer	0.00176	0.0159	CbGeAlD
Bumetanide—Encephalopathy—Fluorouracil—stomach cancer	0.00175	0.0151	CcSEcCtD
Bumetanide—Furosemide—CA2—stomach cancer	0.00175	0.223	CrCbGaD
Bumetanide—SLC10A1—digestive system—stomach cancer	0.00169	0.0153	CbGeAlD
Bumetanide—CFTR—endocrine gland—stomach cancer	0.00168	0.0152	CbGeAlD
Bumetanide—CA5B—hematopoietic system—stomach cancer	0.00168	0.0152	CbGeAlD
Bumetanide—SLC12A2—bone marrow—stomach cancer	0.00165	0.0149	CbGeAlD
Bumetanide—SLC22A11—digestive system—stomach cancer	0.00154	0.014	CbGeAlD
Bumetanide—CFTR—liver—stomach cancer	0.00152	0.0137	CbGeAlD
Bumetanide—Indapamide—CA2—stomach cancer	0.00151	0.193	CrCbGaD
Bumetanide—SLC22A7—digestive system—stomach cancer	0.00151	0.0136	CbGeAlD
Bumetanide—Renal failure—Mitomycin—stomach cancer	0.00149	0.0128	CcSEcCtD
Bumetanide—SLC12A4—lymph node—stomach cancer	0.00148	0.0134	CbGeAlD
Bumetanide—SLC12A2—endocrine gland—stomach cancer	0.00148	0.0134	CbGeAlD
Bumetanide—CA9—endocrine gland—stomach cancer	0.00146	0.0132	CbGeAlD
Bumetanide—Muscle spasms—Floxuridine—stomach cancer	0.00145	0.0125	CcSEcCtD
Bumetanide—SLC10A1—endocrine gland—stomach cancer	0.0014	0.0126	CbGeAlD
Bumetanide—CA5B—pancreas—stomach cancer	0.00137	0.0124	CbGeAlD
Bumetanide—Leukopenia—Floxuridine—stomach cancer	0.00135	0.0116	CcSEcCtD
Bumetanide—PTGS2—blood vessel—stomach cancer	0.00133	0.0121	CbGeAlD
Bumetanide—SLC12A2—liver—stomach cancer	0.00133	0.012	CbGeAlD
Bumetanide—SLCO1A2—hematopoietic system—stomach cancer	0.00131	0.0119	CbGeAlD
Bumetanide—CA12—digestive system—stomach cancer	0.0013	0.0118	CbGeAlD
Bumetanide—Serum creatinine increased—Capecitabine—stomach cancer	0.00128	0.011	CcSEcCtD
Bumetanide—SLC22A11—endocrine gland—stomach cancer	0.00128	0.0115	CbGeAlD
Bumetanide—SLC10A1—liver—stomach cancer	0.00126	0.0114	CbGeAlD
Bumetanide—PTGS2—gall bladder—stomach cancer	0.00126	0.0113	CbGeAlD
Bumetanide—SLC22A8—hematopoietic system—stomach cancer	0.00125	0.0113	CbGeAlD
Bumetanide—SLC22A7—endocrine gland—stomach cancer	0.00124	0.0113	CbGeAlD
Bumetanide—CA14—liver—stomach cancer	0.00124	0.0113	CbGeAlD
Bumetanide—Encephalopathy—Capecitabine—stomach cancer	0.00123	0.0105	CcSEcCtD
Bumetanide—Thrombocytopenia—Floxuridine—stomach cancer	0.0012	0.0104	CcSEcCtD
Bumetanide—SLC22A11—liver—stomach cancer	0.00115	0.0104	CbGeAlD
Bumetanide—SLC22A7—liver—stomach cancer	0.00112	0.0101	CbGeAlD
Bumetanide—Azotaemia—Methotrexate—stomach cancer	0.0011	0.00946	CcSEcCtD
Bumetanide—CA12—endocrine gland—stomach cancer	0.00108	0.00973	CbGeAlD
Bumetanide—Leukopenia—Mitomycin—stomach cancer	0.00106	0.00911	CcSEcCtD
Bumetanide—Tamsulosin—HTR1A—stomach cancer	0.00103	0.131	CrCbGaD
Bumetanide—SLC12A2—lymph node—stomach cancer	0.00102	0.00924	CbGeAlD
Bumetanide—Gastrointestinal pain—Floxuridine—stomach cancer	0.00101	0.00866	CcSEcCtD
Bumetanide—Abdominal pain—Floxuridine—stomach cancer	0.000973	0.00837	CcSEcCtD
Bumetanide—CA5B—endocrine gland—stomach cancer	0.000966	0.00873	CbGeAlD
Bumetanide—Thrombocytopenia—Mitomycin—stomach cancer	0.000945	0.00814	CcSEcCtD
Bumetanide—Encephalopathy—Methotrexate—stomach cancer	0.000912	0.00785	CcSEcCtD
Bumetanide—SLCO1A2—digestive system—stomach cancer	0.000912	0.00824	CbGeAlD
Bumetanide—Serum creatinine increased—Epirubicin—stomach cancer	0.000891	0.00767	CcSEcCtD
Bumetanide—Asthenia—Floxuridine—stomach cancer	0.000883	0.0076	CcSEcCtD
Bumetanide—Hyponatraemia—Irinotecan—stomach cancer	0.000857	0.00737	CcSEcCtD
Bumetanide—Hearing impaired—Docetaxel—stomach cancer	0.000853	0.00735	CcSEcCtD
Bumetanide—Diarrhoea—Floxuridine—stomach cancer	0.000842	0.00725	CcSEcCtD
Bumetanide—Fatigue—Mitomycin—stomach cancer	0.000832	0.00717	CcSEcCtD
Bumetanide—Hearing impaired—Capecitabine—stomach cancer	0.000826	0.00711	CcSEcCtD
Bumetanide—Serum creatinine increased—Doxorubicin—stomach cancer	0.000824	0.0071	CcSEcCtD
Bumetanide—Hepatocellular injury—Docetaxel—stomach cancer	0.000812	0.00699	CcSEcCtD
Bumetanide—CA4—digestive system—stomach cancer	0.000807	0.00729	CbGeAlD
Bumetanide—Blood creatinine increased—Irinotecan—stomach cancer	0.000799	0.00688	CcSEcCtD
Bumetanide—Hyperventilation—Epirubicin—stomach cancer	0.000796	0.00685	CcSEcCtD
Bumetanide—Dehydration—Irinotecan—stomach cancer	0.000793	0.00683	CcSEcCtD
Bumetanide—Vomiting—Floxuridine—stomach cancer	0.000782	0.00673	CcSEcCtD
Bumetanide—Hypokalaemia—Irinotecan—stomach cancer	0.000776	0.00668	CcSEcCtD
Bumetanide—Rash—Floxuridine—stomach cancer	0.000776	0.00668	CcSEcCtD
Bumetanide—Dermatitis—Floxuridine—stomach cancer	0.000775	0.00667	CcSEcCtD
Bumetanide—Headache—Floxuridine—stomach cancer	0.000771	0.00663	CcSEcCtD
Bumetanide—Cramp muscle—Irinotecan—stomach cancer	0.000768	0.00661	CcSEcCtD
Bumetanide—SLCO1A2—endocrine gland—stomach cancer	0.000754	0.00681	CbGeAlD
Bumetanide—CA4—bone marrow—stomach cancer	0.000744	0.00672	CbGeAlD
Bumetanide—Hyperventilation—Doxorubicin—stomach cancer	0.000737	0.00634	CcSEcCtD
Bumetanide—Nausea—Floxuridine—stomach cancer	0.000731	0.00629	CcSEcCtD
Bumetanide—Pancreatitis—Irinotecan—stomach cancer	0.000723	0.00622	CcSEcCtD
Bumetanide—PTGS2—hematopoietic system—stomach cancer	0.00071	0.00642	CbGeAlD
Bumetanide—Asthenia—Mitomycin—stomach cancer	0.000693	0.00596	CcSEcCtD
Bumetanide—SLCO1A2—liver—stomach cancer	0.000679	0.00614	CbGeAlD
Bumetanide—Glycosuria—Epirubicin—stomach cancer	0.000676	0.00582	CcSEcCtD
Bumetanide—CA5B—lymph node—stomach cancer	0.000668	0.00604	CbGeAlD
Bumetanide—CA4—endocrine gland—stomach cancer	0.000667	0.00603	CbGeAlD
Bumetanide—Diarrhoea—Mitomycin—stomach cancer	0.000661	0.00569	CcSEcCtD
Bumetanide—Blood disorder—Epirubicin—stomach cancer	0.000656	0.00565	CcSEcCtD
Bumetanide—Liver injury—Epirubicin—stomach cancer	0.000651	0.00561	CcSEcCtD
Bumetanide—Polyuria—Capecitabine—stomach cancer	0.00065	0.0056	CcSEcCtD
Bumetanide—PTGS2—epithelium—stomach cancer	0.000649	0.00587	CbGeAlD
Bumetanide—Renal failure—Irinotecan—stomach cancer	0.000646	0.00556	CcSEcCtD
Bumetanide—Dizziness—Mitomycin—stomach cancer	0.000638	0.0055	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—stomach cancer	0.000631	0.00543	CcSEcCtD
Bumetanide—Sweating—Irinotecan—stomach cancer	0.00063	0.00543	CcSEcCtD
Bumetanide—Glycosuria—Doxorubicin—stomach cancer	0.000626	0.00539	CcSEcCtD
Bumetanide—PTGS2—smooth muscle tissue—stomach cancer	0.000626	0.00566	CbGeAlD
Bumetanide—Vomiting—Mitomycin—stomach cancer	0.000614	0.00528	CcSEcCtD
Bumetanide—Rash—Mitomycin—stomach cancer	0.000609	0.00524	CcSEcCtD
Bumetanide—Dermatitis—Mitomycin—stomach cancer	0.000608	0.00524	CcSEcCtD
Bumetanide—Blood disorder—Doxorubicin—stomach cancer	0.000607	0.00523	CcSEcCtD
Bumetanide—Headache—Mitomycin—stomach cancer	0.000605	0.00521	CcSEcCtD
Bumetanide—Liver injury—Doxorubicin—stomach cancer	0.000603	0.00519	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—stomach cancer	0.000596	0.00513	CcSEcCtD
Bumetanide—Hyponatraemia—Docetaxel—stomach cancer	0.000592	0.0051	CcSEcCtD
Bumetanide—Hyperuricaemia—Epirubicin—stomach cancer	0.000591	0.00508	CcSEcCtD
Bumetanide—PTGS2—pancreas—stomach cancer	0.000578	0.00523	CbGeAlD
Bumetanide—Nausea—Mitomycin—stomach cancer	0.000573	0.00494	CcSEcCtD
Bumetanide—Hyponatraemia—Capecitabine—stomach cancer	0.000573	0.00493	CcSEcCtD
Bumetanide—Blood uric acid increased—Epirubicin—stomach cancer	0.000558	0.0048	CcSEcCtD
Bumetanide—Musculoskeletal pain—Epirubicin—stomach cancer	0.000555	0.00477	CcSEcCtD
Bumetanide—Dehydration—Docetaxel—stomach cancer	0.000548	0.00472	CcSEcCtD
Bumetanide—Hepatocellular injury—Epirubicin—stomach cancer	0.000548	0.00472	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—stomach cancer	0.000547	0.0047	CcSEcCtD
Bumetanide—Blood creatinine increased—Capecitabine—stomach cancer	0.000535	0.0046	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000531	0.00457	CcSEcCtD
Bumetanide—Cramp muscle—Docetaxel—stomach cancer	0.000531	0.00457	CcSEcCtD
Bumetanide—Dehydration—Capecitabine—stomach cancer	0.000531	0.00457	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—stomach cancer	0.000524	0.00451	CcSEcCtD
Bumetanide—Hypokalaemia—Capecitabine—stomach cancer	0.00052	0.00447	CcSEcCtD
Bumetanide—Blood uric acid increased—Doxorubicin—stomach cancer	0.000516	0.00444	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000514	0.00443	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—stomach cancer	0.000513	0.00442	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—stomach cancer	0.000507	0.00436	CcSEcCtD
Bumetanide—PTGS2—lymphoid tissue—stomach cancer	0.0005	0.00452	CbGeAlD
Bumetanide—PTGS2—digestive system—stomach cancer	0.000494	0.00447	CbGeAlD
Bumetanide—Muscle spasms—Irinotecan—stomach cancer	0.000494	0.00425	CcSEcCtD
Bumetanide—Furosemide—ALB—stomach cancer	0.000488	0.0625	CrCbGaD
Bumetanide—Polyuria—Methotrexate—stomach cancer	0.000484	0.00417	CcSEcCtD
Bumetanide—Abdominal discomfort—Capecitabine—stomach cancer	0.000473	0.00407	CcSEcCtD
Bumetanide—Vertigo—Irinotecan—stomach cancer	0.000462	0.00397	CcSEcCtD
Bumetanide—CA4—lymph node—stomach cancer	0.000461	0.00417	CbGeAlD
Bumetanide—Leukopenia—Irinotecan—stomach cancer	0.00046	0.00396	CcSEcCtD
Bumetanide—PTGS2—bone marrow—stomach cancer	0.000455	0.00412	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000451	0.00388	CcSEcCtD
Bumetanide—Renal failure—Docetaxel—stomach cancer	0.000447	0.00385	CcSEcCtD
Bumetanide—Hyperglycaemia—Capecitabine—stomach cancer	0.000445	0.00383	CcSEcCtD
Bumetanide—Leukopenia—Fluorouracil—stomach cancer	0.00044	0.00379	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000436	0.00375	CcSEcCtD
Bumetanide—Renal failure—Capecitabine—stomach cancer	0.000433	0.00372	CcSEcCtD
Bumetanide—Chest pain—Fluorouracil—stomach cancer	0.000419	0.00361	CcSEcCtD
Bumetanide—Thrombocytopenia—Irinotecan—stomach cancer	0.000411	0.00353	CcSEcCtD
Bumetanide—PTGS2—endocrine gland—stomach cancer	0.000408	0.00369	CbGeAlD
Bumetanide—Hyperhidrosis—Irinotecan—stomach cancer	0.000405	0.00349	CcSEcCtD
Bumetanide—Hyponatraemia—Epirubicin—stomach cancer	0.000399	0.00344	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—stomach cancer	0.000394	0.0503	CrCbGaD
Bumetanide—Thrombocytopenia—Fluorouracil—stomach cancer	0.000393	0.00338	CcSEcCtD
Bumetanide—Hypotension—Irinotecan—stomach cancer	0.000392	0.00337	CcSEcCtD
Bumetanide—Erythema multiforme—Docetaxel—stomach cancer	0.000386	0.00332	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000383	0.00329	CcSEcCtD
Bumetanide—Hypotension—Fluorouracil—stomach cancer	0.000375	0.00323	CcSEcCtD
Bumetanide—Erythema multiforme—Capecitabine—stomach cancer	0.000373	0.00321	CcSEcCtD
Bumetanide—Blood creatinine increased—Epirubicin—stomach cancer	0.000373	0.00321	CcSEcCtD
Bumetanide—Dehydration—Epirubicin—stomach cancer	0.00037	0.00318	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—stomach cancer	0.00037	0.00318	CcSEcCtD
Bumetanide—PTGS2—liver—stomach cancer	0.000368	0.00333	CbGeAlD
Bumetanide—Hypokalaemia—Epirubicin—stomach cancer	0.000362	0.00312	CcSEcCtD
Bumetanide—Fatigue—Irinotecan—stomach cancer	0.000361	0.00311	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—stomach cancer	0.00036	0.0031	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000358	0.00308	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—stomach cancer	0.000352	0.00303	CcSEcCtD
Bumetanide—Fenoprofen—ALB—stomach cancer	0.000351	0.0449	CrCbGaD
Bumetanide—Blood creatinine increased—Doxorubicin—stomach cancer	0.000345	0.00297	CcSEcCtD
Bumetanide—Gastrointestinal pain—Irinotecan—stomach cancer	0.000343	0.00295	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—stomach cancer	0.000342	0.00295	CcSEcCtD
Bumetanide—Muscle spasms—Docetaxel—stomach cancer	0.000341	0.00294	CcSEcCtD
Bumetanide—Pancreatitis—Epirubicin—stomach cancer	0.000337	0.0029	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—stomach cancer	0.000335	0.00288	CcSEcCtD
Bumetanide—Abdominal pain—Irinotecan—stomach cancer	0.000331	0.00285	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000331	0.00285	CcSEcCtD
Bumetanide—Muscle spasms—Capecitabine—stomach cancer	0.000331	0.00285	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000325	0.0028	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—stomach cancer	0.000322	0.00277	CcSEcCtD
Bumetanide—Urticaria—Fluorouracil—stomach cancer	0.000319	0.00275	CcSEcCtD
Bumetanide—Leukopenia—Docetaxel—stomach cancer	0.000318	0.00274	CcSEcCtD
Bumetanide—Sweating—Methotrexate—stomach cancer	0.000314	0.0027	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—stomach cancer	0.000312	0.00268	CcSEcCtD
Bumetanide—Hyperglycaemia—Epirubicin—stomach cancer	0.00031	0.00267	CcSEcCtD
Bumetanide—Vertigo—Capecitabine—stomach cancer	0.000309	0.00266	CcSEcCtD
Bumetanide—Leukopenia—Capecitabine—stomach cancer	0.000308	0.00265	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000304	0.00262	CcSEcCtD
Bumetanide—Arthralgia—Docetaxel—stomach cancer	0.000302	0.0026	CcSEcCtD
Bumetanide—Chest pain—Docetaxel—stomach cancer	0.000302	0.0026	CcSEcCtD
Bumetanide—Renal failure—Epirubicin—stomach cancer	0.000301	0.00259	CcSEcCtD
Bumetanide—Asthenia—Irinotecan—stomach cancer	0.000301	0.00259	CcSEcCtD
Bumetanide—Dry mouth—Docetaxel—stomach cancer	0.000296	0.00255	CcSEcCtD
Bumetanide—Sweating—Epirubicin—stomach cancer	0.000294	0.00253	CcSEcCtD
Bumetanide—Arthralgia—Capecitabine—stomach cancer	0.000293	0.00252	CcSEcCtD
Bumetanide—Chest pain—Capecitabine—stomach cancer	0.000293	0.00252	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—stomach cancer	0.000287	0.00247	CcSEcCtD
Bumetanide—Diarrhoea—Irinotecan—stomach cancer	0.000287	0.00247	CcSEcCtD
Bumetanide—Dry mouth—Capecitabine—stomach cancer	0.000286	0.00246	CcSEcCtD
Bumetanide—Pruritus—Fluorouracil—stomach cancer	0.000284	0.00245	CcSEcCtD
Bumetanide—Thrombocytopenia—Docetaxel—stomach cancer	0.000284	0.00244	CcSEcCtD
Bumetanide—PTGS2—lymph node—stomach cancer	0.000282	0.00255	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000281	0.00242	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—stomach cancer	0.000279	0.0024	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—stomach cancer	0.000278	0.00239	CcSEcCtD
Bumetanide—Dizziness—Irinotecan—stomach cancer	0.000277	0.00239	CcSEcCtD
Bumetanide—Diarrhoea—Fluorouracil—stomach cancer	0.000275	0.00237	CcSEcCtD
Bumetanide—Thrombocytopenia—Capecitabine—stomach cancer	0.000275	0.00237	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—stomach cancer	0.000272	0.00234	CcSEcCtD
Bumetanide—Hyperhidrosis—Capecitabine—stomach cancer	0.000271	0.00234	CcSEcCtD
Bumetanide—Hypotension—Docetaxel—stomach cancer	0.000271	0.00233	CcSEcCtD
Bumetanide—Vomiting—Irinotecan—stomach cancer	0.000267	0.00229	CcSEcCtD
Bumetanide—Dizziness—Fluorouracil—stomach cancer	0.000266	0.00229	CcSEcCtD
Bumetanide—Rash—Irinotecan—stomach cancer	0.000264	0.00228	CcSEcCtD
Bumetanide—Dermatitis—Irinotecan—stomach cancer	0.000264	0.00227	CcSEcCtD
Bumetanide—Headache—Irinotecan—stomach cancer	0.000263	0.00226	CcSEcCtD
Bumetanide—Hypotension—Capecitabine—stomach cancer	0.000262	0.00226	CcSEcCtD
Bumetanide—Erythema multiforme—Epirubicin—stomach cancer	0.00026	0.00224	CcSEcCtD
Bumetanide—Vomiting—Fluorouracil—stomach cancer	0.000255	0.0022	CcSEcCtD
Bumetanide—Rash—Fluorouracil—stomach cancer	0.000253	0.00218	CcSEcCtD
Bumetanide—Dermatitis—Fluorouracil—stomach cancer	0.000253	0.00218	CcSEcCtD
Bumetanide—Headache—Fluorouracil—stomach cancer	0.000252	0.00217	CcSEcCtD
Bumetanide—Fatigue—Docetaxel—stomach cancer	0.00025	0.00215	CcSEcCtD
Bumetanide—Nausea—Irinotecan—stomach cancer	0.000249	0.00214	CcSEcCtD
Bumetanide—Fatigue—Capecitabine—stomach cancer	0.000242	0.00208	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—stomach cancer	0.000241	0.00207	CcSEcCtD
Bumetanide—Nausea—Fluorouracil—stomach cancer	0.000239	0.00205	CcSEcCtD
Bumetanide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000237	0.00204	CcSEcCtD
Bumetanide—Muscle spasms—Epirubicin—stomach cancer	0.00023	0.00198	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—stomach cancer	0.00023	0.00198	CcSEcCtD
Bumetanide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000229	0.00198	CcSEcCtD
Bumetanide—Abdominal pain—Docetaxel—stomach cancer	0.000229	0.00197	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—stomach cancer	0.000229	0.00197	CcSEcCtD
Bumetanide—Urticaria—Capecitabine—stomach cancer	0.000223	0.00192	CcSEcCtD
Bumetanide—Abdominal pain—Capecitabine—stomach cancer	0.000222	0.00191	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—stomach cancer	0.000218	0.00188	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—stomach cancer	0.000218	0.00188	CcSEcCtD
Bumetanide—Vertigo—Epirubicin—stomach cancer	0.000215	0.00185	CcSEcCtD
Bumetanide—Leukopenia—Epirubicin—stomach cancer	0.000214	0.00185	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—stomach cancer	0.000213	0.00183	CcSEcCtD
Bumetanide—Asthenia—Docetaxel—stomach cancer	0.000208	0.00179	CcSEcCtD
Bumetanide—Pruritus—Docetaxel—stomach cancer	0.000205	0.00177	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—stomach cancer	0.000205	0.00176	CcSEcCtD
Bumetanide—Arthralgia—Epirubicin—stomach cancer	0.000204	0.00176	CcSEcCtD
Bumetanide—Chest pain—Epirubicin—stomach cancer	0.000204	0.00176	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—stomach cancer	0.000202	0.00174	CcSEcCtD
Bumetanide—Asthenia—Capecitabine—stomach cancer	0.000201	0.00173	CcSEcCtD
Bumetanide—Dry mouth—Epirubicin—stomach cancer	0.000199	0.00172	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—stomach cancer	0.000199	0.00171	CcSEcCtD
Bumetanide—Pruritus—Capecitabine—stomach cancer	0.000199	0.00171	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—stomach cancer	0.000198	0.00171	CcSEcCtD
Bumetanide—Diarrhoea—Docetaxel—stomach cancer	0.000198	0.00171	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—stomach cancer	0.000195	0.00168	CcSEcCtD
Bumetanide—Diarrhoea—Capecitabine—stomach cancer	0.000192	0.00165	CcSEcCtD
Bumetanide—Dizziness—Docetaxel—stomach cancer	0.000192	0.00165	CcSEcCtD
Bumetanide—Thrombocytopenia—Epirubicin—stomach cancer	0.000191	0.00165	CcSEcCtD
Bumetanide—Hyperhidrosis—Epirubicin—stomach cancer	0.000189	0.00163	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—stomach cancer	0.000189	0.00162	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—stomach cancer	0.000189	0.00162	CcSEcCtD
Bumetanide—Dizziness—Capecitabine—stomach cancer	0.000186	0.0016	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—stomach cancer	0.000185	0.00159	CcSEcCtD
Bumetanide—Vomiting—Docetaxel—stomach cancer	0.000184	0.00159	CcSEcCtD
Bumetanide—Rash—Docetaxel—stomach cancer	0.000183	0.00157	CcSEcCtD
Bumetanide—Hypotension—Epirubicin—stomach cancer	0.000183	0.00157	CcSEcCtD
Bumetanide—Dermatitis—Docetaxel—stomach cancer	0.000183	0.00157	CcSEcCtD
Bumetanide—Headache—Docetaxel—stomach cancer	0.000182	0.00156	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—stomach cancer	0.00018	0.00155	CcSEcCtD
Bumetanide—Vomiting—Capecitabine—stomach cancer	0.000178	0.00154	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000177	0.00152	CcSEcCtD
Bumetanide—Rash—Capecitabine—stomach cancer	0.000177	0.00152	CcSEcCtD
Bumetanide—Dermatitis—Capecitabine—stomach cancer	0.000177	0.00152	CcSEcCtD
Bumetanide—Headache—Capecitabine—stomach cancer	0.000176	0.00151	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000175	0.00151	CcSEcCtD
Bumetanide—Nausea—Docetaxel—stomach cancer	0.000172	0.00148	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000171	0.00147	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—stomach cancer	0.000169	0.00145	CcSEcCtD
Bumetanide—Fatigue—Epirubicin—stomach cancer	0.000169	0.00145	CcSEcCtD
Bumetanide—Nausea—Capecitabine—stomach cancer	0.000167	0.00143	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—stomach cancer	0.000166	0.00143	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—stomach cancer	0.000165	0.00142	CcSEcCtD
Bumetanide—Gastrointestinal pain—Epirubicin—stomach cancer	0.00016	0.00138	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—stomach cancer	0.000156	0.00134	CcSEcCtD
Bumetanide—Urticaria—Epirubicin—stomach cancer	0.000155	0.00134	CcSEcCtD
Bumetanide—Abdominal pain—Epirubicin—stomach cancer	0.000155	0.00133	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—stomach cancer	0.00015	0.00129	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000148	0.00127	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—stomach cancer	0.000148	0.00127	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—stomach cancer	0.000144	0.00124	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—stomach cancer	0.000143	0.00123	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—stomach cancer	0.000143	0.00123	CcSEcCtD
Bumetanide—Asthenia—Epirubicin—stomach cancer	0.00014	0.00121	CcSEcCtD
Bumetanide—Pruritus—Epirubicin—stomach cancer	0.000138	0.00119	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—stomach cancer	0.000138	0.00119	CcSEcCtD
Bumetanide—Diarrhoea—Epirubicin—stomach cancer	0.000134	0.00115	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—stomach cancer	0.000133	0.00114	CcSEcCtD
Bumetanide—Rash—Methotrexate—stomach cancer	0.000132	0.00113	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—stomach cancer	0.000132	0.00113	CcSEcCtD
Bumetanide—Headache—Methotrexate—stomach cancer	0.000131	0.00113	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—stomach cancer	0.00013	0.00112	CcSEcCtD
Bumetanide—Dizziness—Epirubicin—stomach cancer	0.000129	0.00111	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—stomach cancer	0.000128	0.0011	CcSEcCtD
Bumetanide—Vomiting—Epirubicin—stomach cancer	0.000124	0.00107	CcSEcCtD
Bumetanide—Nausea—Methotrexate—stomach cancer	0.000124	0.00107	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—stomach cancer	0.000124	0.00107	CcSEcCtD
Bumetanide—Rash—Epirubicin—stomach cancer	0.000123	0.00106	CcSEcCtD
Bumetanide—Dermatitis—Epirubicin—stomach cancer	0.000123	0.00106	CcSEcCtD
Bumetanide—Headache—Epirubicin—stomach cancer	0.000122	0.00105	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—stomach cancer	0.00012	0.00103	CcSEcCtD
Bumetanide—Nausea—Epirubicin—stomach cancer	0.000116	0.001	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—stomach cancer	0.000115	0.00099	CcSEcCtD
Bumetanide—Rash—Doxorubicin—stomach cancer	0.000114	0.000982	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—stomach cancer	0.000114	0.000981	CcSEcCtD
Bumetanide—Headache—Doxorubicin—stomach cancer	0.000113	0.000975	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—stomach cancer	0.000107	0.000925	CcSEcCtD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	3.33e-05	0.000201	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CAV1—stomach cancer	3.32e-05	0.000201	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APOA1—stomach cancer	3.31e-05	0.0002	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—APOA1—stomach cancer	3.29e-05	0.000198	CbGpPWpGaD
Bumetanide—CA7—Metabolism—MTHFR—stomach cancer	3.28e-05	0.000198	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—MTHFR—stomach cancer	3.28e-05	0.000198	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ENO1—stomach cancer	3.26e-05	0.000197	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	3.25e-05	0.000196	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CAV1—stomach cancer	3.24e-05	0.000195	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.24e-05	0.000195	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—APOA1—stomach cancer	3.23e-05	0.000195	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ERCC2—stomach cancer	3.23e-05	0.000195	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FBP1—stomach cancer	3.2e-05	0.000193	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPP2R1A—stomach cancer	3.19e-05	0.000192	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	3.17e-05	0.000192	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TYMP—stomach cancer	3.16e-05	0.000191	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—FADS1—stomach cancer	3.16e-05	0.000191	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PGLS—stomach cancer	3.15e-05	0.00019	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BLVRB—stomach cancer	3.15e-05	0.00019	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTP1—stomach cancer	3.12e-05	0.000189	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—stomach cancer	3.08e-05	0.000186	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HMOX1—stomach cancer	3.08e-05	0.000186	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.04e-05	0.000184	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPP2R1A—stomach cancer	3.04e-05	0.000183	CbGpPWpGaD
Bumetanide—CA12—Metabolism—MTHFR—stomach cancer	3.04e-05	0.000183	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CAV1—stomach cancer	3.02e-05	0.000183	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CAV1—stomach cancer	3.02e-05	0.000183	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APOA1—stomach cancer	3.02e-05	0.000182	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APOA1—stomach cancer	3.02e-05	0.000182	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPAP2A—stomach cancer	3.01e-05	0.000182	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTP1—stomach cancer	2.98e-05	0.00018	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SREBF2—stomach cancer	2.96e-05	0.000179	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HMOX1—stomach cancer	2.94e-05	0.000178	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—RORA—stomach cancer	2.93e-05	0.000177	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PPARG—stomach cancer	2.92e-05	0.000176	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TYMS—stomach cancer	2.9e-05	0.000175	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.89e-05	0.000175	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD44—stomach cancer	2.89e-05	0.000174	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTM1—stomach cancer	2.87e-05	0.000173	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—stomach cancer	2.87e-05	0.000173	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PGAM1—stomach cancer	2.85e-05	0.000172	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PPARG—stomach cancer	2.85e-05	0.000172	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	2.84e-05	0.000172	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	2.83e-05	0.000171	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—stomach cancer	2.82e-05	0.00017	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CAV1—stomach cancer	2.8e-05	0.000169	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOA1—stomach cancer	2.79e-05	0.000169	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TYMS—stomach cancer	2.77e-05	0.000167	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—APOA1—stomach cancer	2.76e-05	0.000167	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—stomach cancer	2.76e-05	0.000166	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALDOB—stomach cancer	2.74e-05	0.000166	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTM1—stomach cancer	2.74e-05	0.000165	CbGpPWpGaD
Bumetanide—PTGS2—Disease—WIF1—stomach cancer	2.72e-05	0.000164	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ERCC2—stomach cancer	2.7e-05	0.000163	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	2.7e-05	0.000163	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	2.69e-05	0.000163	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CKB—stomach cancer	2.68e-05	0.000162	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FBP1—stomach cancer	2.68e-05	0.000162	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NDUFA2—stomach cancer	2.68e-05	0.000162	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA1—stomach cancer	2.68e-05	0.000162	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PPARG—stomach cancer	2.66e-05	0.00016	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PPARG—stomach cancer	2.66e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.64e-05	0.00016	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—stomach cancer	2.63e-05	0.000159	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	2.62e-05	0.000158	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—stomach cancer	2.6e-05	0.000157	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.59e-05	0.000156	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.58e-05	0.000156	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ERCC2—stomach cancer	2.58e-05	0.000156	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—stomach cancer	2.57e-05	0.000155	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—stomach cancer	2.56e-05	0.000155	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL13—stomach cancer	2.56e-05	0.000155	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL18—stomach cancer	2.56e-05	0.000155	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALOX5—stomach cancer	2.55e-05	0.000154	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MTHFR—stomach cancer	2.54e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLIN2—stomach cancer	2.52e-05	0.000152	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NOS3—stomach cancer	2.51e-05	0.000152	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DPYD—stomach cancer	2.51e-05	0.000151	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PPARG—stomach cancer	2.46e-05	0.000149	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPP2R1A—stomach cancer	2.46e-05	0.000148	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—APOA1—stomach cancer	2.45e-05	0.000148	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA2—stomach cancer	2.45e-05	0.000148	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.45e-05	0.000148	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NOS3—stomach cancer	2.45e-05	0.000148	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RNF43—stomach cancer	2.43e-05	0.000146	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MTHFR—stomach cancer	2.42e-05	0.000146	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTP1—stomach cancer	2.41e-05	0.000145	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PGAM1—stomach cancer	2.39e-05	0.000144	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NT5E—stomach cancer	2.39e-05	0.000144	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—stomach cancer	2.39e-05	0.000144	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—stomach cancer	2.39e-05	0.000144	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPS15—stomach cancer	2.39e-05	0.000144	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPS21—stomach cancer	2.39e-05	0.000144	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMOX1—stomach cancer	2.38e-05	0.000143	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CAV1—stomach cancer	2.34e-05	0.000141	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.34e-05	0.000141	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOA1—stomach cancer	2.34e-05	0.000141	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.33e-05	0.000141	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	2.31e-05	0.000139	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—stomach cancer	2.3e-05	0.000139	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NOS3—stomach cancer	2.29e-05	0.000138	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NOS3—stomach cancer	2.29e-05	0.000138	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLCE1—stomach cancer	2.28e-05	0.000138	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDH7A1—stomach cancer	2.28e-05	0.000138	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.27e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—stomach cancer	2.26e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	2.26e-05	0.000137	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TYMS—stomach cancer	2.24e-05	0.000135	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—stomach cancer	2.24e-05	0.000135	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.24e-05	0.000135	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CAV1—stomach cancer	2.23e-05	0.000135	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOA1—stomach cancer	2.23e-05	0.000135	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTT1—stomach cancer	2.22e-05	0.000134	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—stomach cancer	2.21e-05	0.000134	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—stomach cancer	2.21e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.21e-05	0.000133	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2A6—stomach cancer	2.19e-05	0.000132	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—stomach cancer	2.19e-05	0.000132	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—UMPS—stomach cancer	2.19e-05	0.000132	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKR1C3—stomach cancer	2.13e-05	0.000129	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NOS3—stomach cancer	2.12e-05	0.000128	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—stomach cancer	2.09e-05	0.000126	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—stomach cancer	2.09e-05	0.000126	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ERCC2—stomach cancer	2.08e-05	0.000126	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ENO1—stomach cancer	2.08e-05	0.000125	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—stomach cancer	2.07e-05	0.000125	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARG—stomach cancer	2.06e-05	0.000124	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.04e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.04e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PDHA1—stomach cancer	2.03e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ECHS1—stomach cancer	2.03e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ALDOB—stomach cancer	1.98e-05	0.000119	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARG—stomach cancer	1.96e-05	0.000119	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTHFR—stomach cancer	1.96e-05	0.000118	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—stomach cancer	1.94e-05	0.000117	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL15—stomach cancer	1.94e-05	0.000117	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—stomach cancer	1.94e-05	0.000117	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.93e-05	0.000116	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TYMP—stomach cancer	1.91e-05	0.000115	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FADS1—stomach cancer	1.91e-05	0.000115	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NPM1—stomach cancer	1.9e-05	0.000115	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.87e-05	0.000113	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—stomach cancer	1.85e-05	0.000112	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD44—stomach cancer	1.84e-05	0.000111	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RBP4—stomach cancer	1.84e-05	0.000111	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.83e-05	0.000111	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.83e-05	0.000111	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	1.83e-05	0.00011	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPS26—stomach cancer	1.81e-05	0.000109	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CAV1—stomach cancer	1.8e-05	0.000109	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOA1—stomach cancer	1.8e-05	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPIA—stomach cancer	1.79e-05	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SREBF2—stomach cancer	1.79e-05	0.000108	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.79e-05	0.000108	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NOS3—stomach cancer	1.77e-05	0.000107	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RORA—stomach cancer	1.77e-05	0.000107	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—stomach cancer	1.76e-05	0.000107	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.75e-05	0.000105	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.73e-05	0.000105	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NOS3—stomach cancer	1.69e-05	0.000102	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDOB—stomach cancer	1.66e-05	0.0001	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—stomach cancer	1.62e-05	9.77e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.59e-05	9.61e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARG—stomach cancer	1.59e-05	9.58e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPP2R1A—stomach cancer	1.57e-05	9.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.56e-05	9.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.56e-05	9.41e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—stomach cancer	1.54e-05	9.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALOX5—stomach cancer	1.54e-05	9.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.54e-05	9.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPS19—stomach cancer	1.54e-05	9.29e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKR1C3—stomach cancer	1.54e-05	9.29e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTP1—stomach cancer	1.54e-05	9.28e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMOX1—stomach cancer	1.52e-05	9.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DPYD—stomach cancer	1.51e-05	9.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO1—stomach cancer	1.5e-05	9.05e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TYMS—stomach cancer	1.43e-05	8.63e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—stomach cancer	1.43e-05	8.61e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CA—stomach cancer	1.41e-05	8.54e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—stomach cancer	1.41e-05	8.53e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CA—stomach cancer	1.38e-05	8.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.37e-05	8.29e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NOS3—stomach cancer	1.36e-05	8.24e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPS6—stomach cancer	1.36e-05	8.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTT1—stomach cancer	1.34e-05	8.09e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD44—stomach cancer	1.33e-05	8.03e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ERCC2—stomach cancer	1.33e-05	8.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2A6—stomach cancer	1.32e-05	7.99e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKR1C3—stomach cancer	1.29e-05	7.78e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CA—stomach cancer	1.29e-05	7.76e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CA—stomach cancer	1.29e-05	7.76e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO1—stomach cancer	1.26e-05	7.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HBEGF—stomach cancer	1.25e-05	7.55e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTHFR—stomach cancer	1.25e-05	7.54e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—stomach cancer	1.25e-05	7.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.23e-05	7.45e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CA—stomach cancer	1.19e-05	7.19e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CAV1—stomach cancer	1.15e-05	6.95e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOA1—stomach cancer	1.15e-05	6.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPP2R1A—stomach cancer	1.13e-05	6.82e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD44—stomach cancer	1.11e-05	6.72e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.1e-05	6.64e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SMAD4—stomach cancer	1.05e-05	6.34e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARG—stomach cancer	1.01e-05	6.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FYN—stomach cancer	9.96e-06	6.02e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CA—stomach cancer	9.96e-06	6.01e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERCC2—stomach cancer	9.58e-06	5.78e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CA—stomach cancer	9.5e-06	5.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPP2R1A—stomach cancer	9.46e-06	5.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGFR2—stomach cancer	9.35e-06	5.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTP1—stomach cancer	9.28e-06	5.61e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMOX1—stomach cancer	9.16e-06	5.53e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—stomach cancer	9.1e-06	5.5e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTHFR—stomach cancer	9e-06	5.44e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NOS3—stomach cancer	8.71e-06	5.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TYMS—stomach cancer	8.63e-06	5.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS2—stomach cancer	8.56e-06	5.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—stomach cancer	8.53e-06	5.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CAV1—stomach cancer	8.3e-06	5.01e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOA1—stomach cancer	8.29e-06	5e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ERCC2—stomach cancer	8.02e-06	4.84e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—stomach cancer	7.96e-06	4.81e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6ST—stomach cancer	7.87e-06	4.75e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CA—stomach cancer	7.68e-06	4.64e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APC—stomach cancer	7.56e-06	4.57e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTHFR—stomach cancer	7.54e-06	4.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6R—stomach cancer	7.02e-06	4.24e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CAV1—stomach cancer	6.95e-06	4.2e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA1—stomach cancer	6.94e-06	4.19e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.64e-06	4.01e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SERPINE1—stomach cancer	6.58e-06	3.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RHOA—stomach cancer	6.34e-06	3.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS3—stomach cancer	6.28e-06	3.79e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARG—stomach cancer	6.11e-06	3.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB2—stomach cancer	5.87e-06	3.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—stomach cancer	5.5e-06	3.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1B—stomach cancer	5.44e-06	3.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NOS3—stomach cancer	5.26e-06	3.18e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1A—stomach cancer	5.02e-06	3.03e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CA—stomach cancer	4.9e-06	2.96e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—stomach cancer	4.48e-06	2.7e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK3—stomach cancer	4.28e-06	2.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—stomach cancer	4.16e-06	2.51e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK1—stomach cancer	4.07e-06	2.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—stomach cancer	4.07e-06	2.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KRAS—stomach cancer	3.85e-06	2.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CA—stomach cancer	3.53e-06	2.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HRAS—stomach cancer	3.27e-06	1.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—stomach cancer	3.13e-06	1.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CA—stomach cancer	2.96e-06	1.79e-05	CbGpPWpGaD
